Vlaeminck-Guillem V - Search Results

1

Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study.

Govers TM, Hessels D, Vlaeminck-Guillem V, Schmitz-Dräger BJ, Stief CG, Martinez-Ballesteros C, Ferro M, Borque-Fernando A, Rubio-Briones J, Sedelaar JPM, van Criekinge W, Schalken JA. Govers TM, et al. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):101-109. doi: 10.1038/s41391-018-0076-3. Epub 2018 Aug 20. Prostate Cancer Prostatic Dis. 2019. PMID: 30127462

2

Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer before Initial Prostate Biopsy.

Haese A, Trooskens G, Steyaert S, Hessels D, Brawer M, Vlaeminck-Guillem V, Ruffion A, Tilki D, Schalken J, Groskopf J, Van Criekinge W. Haese A, et al. J Urol. 2019 Aug;202(2):256-263. doi: 10.1097/JU.0000000000000293. Epub 2019 Jul 8. J Urol. 2019. PMID: 31026217

3

Additional value of PCA3 density to predict initial prostate biopsy outcome.

Ruffion A, Perrin P, Devonec M, Champetier D, Decaussin M, Paparel P, Vlaeminck-Guillem V. Ruffion A, et al. World J Urol. 2014 Aug;32(4):917-23. doi: 10.1007/s00345-014-1251-3. Epub 2014 Feb 6. World J Urol. 2014. PMID: 24500192

4

PCA3 and PCA3-based nomograms improve diagnostic accuracy in patients undergoing first prostate biopsy.

Ruffion A, Devonec M, Champetier D, Decaussin-Petrucci M, Rodriguez-Lafrasse C, Paparel P, Perrin P, Vlaeminck-Guillem V. Ruffion A, et al. Int J Mol Sci. 2013 Aug 29;14(9):17767-80. doi: 10.3390/ijms140917767. Int J Mol Sci. 2013. PMID: 23994838 Free PMC article.

5

[Value of urinary PCA3 test for prostate cancer diagnosis].

Vlaeminck-Guillem V, Ruffion A, Andre J. Vlaeminck-Guillem V, et al. Prog Urol. 2008 May;18(5):259-65. doi: 10.1016/j.purol.2008.03.029. Epub 2008 May 16. Prog Urol. 2008. PMID: 18538269 Review. French.

6

Exosomes and prostate cancer management.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Semin Cancer Biol. 2022 Nov;86(Pt 1):101-111. doi: 10.1016/j.semcancer.2021.08.004. Epub 2021 Aug 9. Semin Cancer Biol. 2022. PMID: 34384877 Review.

7

Chronic prostatitis does not influence urinary PCA3 score.

Vlaeminck-Guillem V, Bandel M, Cottancin M, Rodriguez-Lafrasse C, Bohbot JM, Sednaoui P. Vlaeminck-Guillem V, et al. Prostate. 2012 Apr;72(5):549-54. doi: 10.1002/pros.21457. Epub 2011 Jul 14. Prostate. 2012. PMID: 21761426

8

Urinary PCA3 score predicts prostate cancer multifocality.

Vlaeminck-Guillem V, Devonec M, Colombel M, Rodriguez-Lafrasse C, Decaussin-Petrucci M, Ruffion A. Vlaeminck-Guillem V, et al. J Urol. 2011 Apr;185(4):1234-9. doi: 10.1016/j.juro.2010.11.072. Epub 2011 Feb 22. J Urol. 2011. PMID: 21334023

9

Prognostic accuracy of prostate health index and urinary prostate cancer antigen 3 in predicting pathologic features after radical prostatectomy.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Urol Oncol. 2015 Nov;33(11):498. doi: 10.1016/j.urolonc.2015.05.027. Epub 2015 Jun 23. Urol Oncol. 2015. PMID: 26116413 No abstract available.

10

Extracellular Vesicles in Prostate Cancer Carcinogenesis, Diagnosis, and Management.

Vlaeminck-Guillem V. Vlaeminck-Guillem V. Front Oncol. 2018 Jun 13;8:222. doi: 10.3389/fonc.2018.00222. eCollection 2018. Front Oncol. 2018. PMID: 29951375 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page